
HIV-1 entry inhibition by small-molecule CCR5 antagonists: A combined molecular modeling and mutant study using a high-throughput assay
Keywords: ماریوکر; HIV-1; CCR5; Small molecule antagonists; Aplaviroc; Maraviroc; Vicriviroc; Mutagenesis; Antifusogenic assay; Homology modeling; Binding site characterization